Direxion Daily S&P Biotech Bull 3X Shares (LABU) - Stock Analysis
Last updated: Apr 6, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Flagged as a conditional short-term "hot idea" for nimble traders: 3x leveraged biotech ETF up ~9.4% over 21 days, ~11% above its 21-day SMA, with a fresh high at 173.4 and a new ~$3.2M JPM stake. A continuation above 173.4 with momentum could yield outsized gains in the next few sessions, though volatility and reversal risk are high.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Description
The fund allocates at least 80% of its net assets, plus any borrowings for investment, to securities and instruments that track or replicate a biotechnology industry index, including exchange-traded funds and products that provide daily leveraged exposure. The referenced index measures performance of the biotechnology sub-industry under the Global Industry Classification Standards. The fund is non-diversified.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 6 | Apr 13 | LABU | Direxion Daily S&P Biotech Bull 3X Shares | Flagged as a conditional short-term "hot idea" for nimble traders: 3x leveraged biotech ETF up ~9.4% over 21 days, ~11% above its 21-day SMA, with a fresh high at 173.4 and a new ~$3.2M JPM stake. A continuation above 173.4 with momentum could yield outsized gains in the next few sessions, though volatility and reversal risk are high. | Active | +0.0% |